These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 29353165)

  • 1. Prognostic value of primary tumour resection in synchronous metastatic colorectal cancer: Individual patient data analysis of first-line randomised trials from the ARCAD database.
    van Rooijen KL; Shi Q; Goey KKH; Meyers J; Heinemann V; Diaz-Rubio E; Aranda E; Falcone A; Green E; de Gramont A; Sargent DJ; Punt CJA; Koopman M
    Eur J Cancer; 2018 Mar; 91():99-106. PubMed ID: 29353165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Analysis of Relationship Between RAS Mutations and Prognosis of Primary Tumour Resection for Metastatic Colorectal Cancer Patients.
    Liang L; Tian J; Yu Y; Wang Z; Peng K; Liu R; Wang Y; Xu X; Li H; Zhuang R; Cui Y; Zhu C; Liu T
    Cell Physiol Biochem; 2018; 50(2):768-782. PubMed ID: 30308491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary Tumor Resection and Overall Survival in Patients With Metastatic Colorectal Cancer Treated With Palliative Intent.
    Wong SF; Wong HL; Field KM; Kosmider S; Tie J; Wong R; Tacey M; Shapiro J; Nott L; Richardson G; Cooray P; Jones I; Croxford M; Gibbs P
    Clin Colorectal Cancer; 2016 Sep; 15(3):e125-32. PubMed ID: 26803709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modern-day palliative chemotherapy for metastatic colorectal cancer: does colonic resection affect survival?
    Lau JWL; Chang HSY; Lee KY; Gwee YX; Lee WQ; Chong CS
    ANZ J Surg; 2018 Nov; 88(11):E772-E777. PubMed ID: 29938886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significant increase of synchronous disease in first-line metastatic colorectal cancer trials: Results of a systematic review.
    Goey KK; 't Lam-Boer J; de Wilt JH; Punt CJ; van Oijen MG; Koopman M
    Eur J Cancer; 2016 Dec; 69():166-177. PubMed ID: 27821320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of primary tumor resection in colorectal cancer patients with synchronous unresectable metastasis.
    Kim MS; Chung M; Ahn JB; Kim CW; Cho MS; Shin SJ; Baek SJ; Hur H; Min BS; Baik SH; Kim NK
    J Surg Oncol; 2014 Aug; 110(2):214-21. PubMed ID: 24668581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is primary tumour resection associated with survival improvement in patients with colorectal cancer and unresectable synchronous metastases? A pooled analysis of individual data from four randomised trials.
    Faron M; Pignon JP; Malka D; Bourredjem A; Douillard JY; Adenis A; Elias D; Bouché O; Ducreux M
    Eur J Cancer; 2015 Jan; 51(2):166-76. PubMed ID: 25465185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary Tumour Resection Could Improve the Survival of Unresectable Metastatic Colorectal Cancer Patients Receiving Bevacizumab-Containing Chemotherapy.
    Wang Z; Liang L; Yu Y; Wang Y; Zhuang R; Chen Y; Cui Y; Zhou Y; Liu T
    Cell Physiol Biochem; 2016; 39(3):1239-46. PubMed ID: 27595400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients.
    Song A; Eo W; Lee S
    World J Gastroenterol; 2015 Nov; 21(43):12410-20. PubMed ID: 26604648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upfront primary tumour resection and survival in synchronous metastatic colorectal cancer according to primary tumour location and RAS status: Pooled analysis of the Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD).
    Benavides M; Gómez-España A; García-Alfonso P; González CG; Viéitez JM; Rivera F; Safont MJ; Abad A; Sastre J; Valladares-Ayerbes M; Carrato A; González-Flores E; Robles L; Salud A; Alonso-Orduña V; Montagut C; Asensio E; Díaz-Rubio E; Aranda E;
    Eur J Surg Oncol; 2022 May; 48(5):1123-1132. PubMed ID: 34872775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disease-Free Survival after Simultaneous or Delayed Resection of Synchronous Colorectal Liver Metastasis and Primary Cancer.
    Bigourdan JM; Faber B; Rayar M; Chirpaz E; Boucher E; Boudjema K
    Hepatogastroenterology; 2014 Jun; 61(132):1074-81. PubMed ID: 26158168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Australian contemporary management of synchronous metastatic colorectal cancer.
    Malouf P; Gibbs P; Shapiro J; Sockler J; Bell S
    ANZ J Surg; 2018 Jan; 88(1-2):71-76. PubMed ID: 27122066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benefit of Surgical Resection of the Primary Tumor in Patients Undergoing Chemotherapy for Stage IV Colorectal Cancer with Unresected Metastasis.
    Maroney S; de Paz CC; Reeves ME; Garberoglio C; Raskin E; Senthil M; Namm JP; Solomon N
    J Gastrointest Surg; 2018 Mar; 22(3):460-466. PubMed ID: 29124549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synchronous polyps predict metachronous colorectal lesions after curative resection of colorectal cancer.
    Pozza A; Ruffolo C; Fiorot A; Padoan L; Erroi F; Massani M; Caratozzolo E; Bonariol L; Ferrara F; Norberto L; Castoro C; Bassi N; Scarpa M
    Acta Chir Belg; 2016 Aug; 116(4):225-230. PubMed ID: 27426670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of primary tumour resection on survival of patients with colorectal cancer and synchronous metastases treated by chemotherapy: results from the multicenter, randomised trial Fédération Francophone de Cancérologie Digestive 9601.
    Ferrand F; Malka D; Bourredjem A; Allonier C; Bouché O; Louafi S; Boige V; Mousseau M; Raoul JL; Bedenne L; Leduc B; Deguiral P; Faron M; Pignon JP; Ducreux M
    Eur J Cancer; 2013 Jan; 49(1):90-7. PubMed ID: 22926014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of colorectal cancer patients with peritoneal carcinomatosis treated with chemotherapy with and without targeted therapy.
    Klaver YL; Simkens LH; Lemmens VE; Koopman M; Teerenstra S; Bleichrodt RP; de Hingh IH; Punt CJ
    Eur J Surg Oncol; 2012 Jul; 38(7):617-23. PubMed ID: 22572106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival outcomes following primary tumor resection for patients with incurable metastatic colorectal carcinoma: Experience from a single institution.
    Lau JW; Chang HS; Lee KY; Gwee YX; Lee WQ; Chong CS
    J Dig Dis; 2018 Sep; 19(9):550-560. PubMed ID: 30117288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. METACHRONOUS COLORECTAL LIVER METASTASES HAS BETTER PROGNOSIS - IS IT TRUE?
    Quireze Junior C; Brasil AMS; Morais LK; Campion ERL; Taveira EJF; Rassi MC
    Arq Gastroenterol; 2018; 55(3):258-263. PubMed ID: 30540088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival impact of surgical resection of primary tumor in patients with stage IV colorectal cancer: results from a large population-based cohort study.
    Ahmed S; Leis A; Fields A; Chandra-Kanthan S; Haider K; Alvi R; Reeder B; Pahwa P
    Cancer; 2014 Mar; 120(5):683-91. PubMed ID: 24222180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bevacizumab Efficacy Is Influenced by Primary Tumor Resection in First-Line Treatment of Metastatic Colorectal Cancer in a Retrospective Multicenter Study.
    Cabart M; Frénel JS; Campion L; Ramée JF; Dupuis O; Senellart H; Hiret S; Douillard JY; Bennouna J
    Clin Colorectal Cancer; 2016 Dec; 15(4):e165-e174. PubMed ID: 27256668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.